Stocks/ATHE

ATHE three-lens brief

Evidence-based stock research on ATHE. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.

52-week rangeas of 08:00 ET
$2.66$4.11$5.89

Performance

1W
-9.1%
1M
-12.6%
3M
6M
YTD
1Y
3Y
5Y
ATHE · Nightly brief
Inspect

Price down 8.67% in the last session — a material single-day move. · Trading >3% below the 50-day MA — short-term weakness.

  • Price down 8.67% in the last session — a material single-day move.
  • Trading >3% below the 50-day MA — short-term weakness.
  • Underperforming SPY by 11.3pp over 30 days.
  • Analyst mean target $13.25 — 222% above current (4 analysts).

ATHE closed at $4.11 (-8.67%) as of 2026-09-11. Market cap: $74.84M. Price is below the 50-day MA and above the 200-day MA. Positives: analyst mean target $13.25 — 222% above current (4 analysts).. Concerns: price down 8.67% in the last session — a material single-day move.; trading >3% below the 50-day MA — short-term weakness..

Market ✓
Informational only · Not investment advice
Three-lens method

Why three lenses on ATHE, not one.

A single reasoning model has blind spots it doesn’t know about. We examine ATHEacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.

Read the full methodology
Embed this brief

Drop it in your newsletter or blog.

Free to embed. Updates every 6 hours. Links back to the full brief.

<iframe
  src="https://clearpathinvest.app/embed/ATHE"
  width="100%" height="420" frameborder="0"
  loading="lazy"
  title="ClearPath ATHE brief"></iframe>